Search

Your search keyword '"Castiglione F"' showing total 1,750 results

Search Constraints

Start Over You searched for: Author "Castiglione F" Remove constraint Author: "Castiglione F"
1,750 results on '"Castiglione F"'

Search Results

1. Exclusive Enteral Nutrition in Adult Crohn’s Disease: an Overview of Clinical Practice and Perceived Barriers

2. Ultrasonography-Based Management of Sclerosing Mesenteritis: From Diagnosis to Follow-Up

3. Adherence in ulcerative colitis: an overview

5. OC.07.5: BOWEL URGENCY IN PATIENTS WITH ULCERATIVE COLITIS: PREVALENCE AND ASSOCIATION WITH CLINICAL, ENDOSCOPIC DATA AND DISABILITY

6. T.05.2: REDUCING DIAGNOSTIC DELAY OF EXTRA-INTESTINAL MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A COMPARATIVE STUDY BETWEEN A MULTIDISCIPLINARY IMMUNE-MEDIATED DISEASES OUTPATIENT CLINIC AND CONVENTIONAL REFERRAL SPECIALISTS

8. OC.07.2: ASSESSMENT OF VEDOLIZUMAB AND USTEKINUMAB IN ELDERLY (AVENUE) PATIENTS WITH CROHN'S DISEASE (CD): AN IG-IBD STUDY

10. BOC.02.8: DEFINING DIAGNOSTIC ULTRASONOGRAPHIC PARAMETERS IN ULCERATIVE COLITIS: A LONGITUDINAL PROSPECTIVE MULTICENTER STUDY

11. Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial

13. Water Vapor Thermal Therapy vs. TURP for the treatment of benign prostatic obstruction: A Multicenter Propensity-Score Matched Pair “tetrafecta” Analysis (URAN Collaborative Group)

15. P1016 Real-world data on sequential therapy in moderate-to-severe UC: Unveiling second-line strategies after anti-TNF failure

17. P1128 Reducing diagnostic delay of Extra-Intestinal Manifestations in patients with Inflammatory Bowel Disease: a comparative study between a multidisciplinary immune-mediated diseases outpatient clinic and conventional referral specialists

18. P413 Bowel Urgency in patients with Ulcerative Colitis: prevalence and association with clinical, endoscopic data and disability

19. P328 Ischemic Ulcers Do Not Significantly Impact The Endoscopic Recurrence Score In Crohn’s Disease: A Multicenter Comparative Study After Right-Side Resections For Crohn’s Disease And Colorectal Cancer

23. OC.14.2 LACK OF SEROCONVERSION FOLLOWING COVID-19 VACCINATION, BUT NOT TREATMENT, IS AN INDEPENDENT RISK FACTOR FOR BREAKTHROUGH SARS-COV-2 INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IGIBD STUDY

24. OC.04.2 SURGICAL PREVENTION OF ANASTOMOTIC RECURRENCE BY EXCLUDING MESENTERY IN CROHN'S DISEASE (THE SUPREMECD TRIAL): KONO-S ANASTOMOSIS REDUCES ENDOSCOPIC AND SURGICAL POST-OPERATIVE RECURRENCE IN CROHN'S DISEASE

25. OC.10.6 IT IS TIME TO GROW UP: READINESS IS ASSOCIATED WITH BETTER CLINICAL OUTCOMES IN A PROSPECTIVE STUDY OF PEDIATRIC TRANSITION PATIENTS WITH INFLAMMATORY BOWEL DISEASE

28. Active surveillance for very small renal masses: Analysis from an observational prospective trial (NCT03804320)

30. P605 Real life efficacy of tofacitinib in different situation in ulcerative colitis: a retrospective worldwide multicentre collaborative study

33. P387 Different rate of transmural remission between first and second line of biologic treatment in Crohn's disease

35. P218 It is time to grow up: readiness is associated with better outcomes in a prospective study of pediatric transition patients with Inflammatory Bowel Disease

37. P455 Comparison of two strategies for the management of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study

40. Multi-scale Simulation of T Helper Lymphocyte Differentiation

41. Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial

42. Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study

45. List of Contributors

47. PC.01.4 REDUCED IMMUNE RESPONSE INDUCED BY TWO DOSES OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IG-IBD STUDY

49. T.06.8 COMPARATIVE OBJECTIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN A REAL-LIFE COHORT OF ACTIVE CROHN’S DISEASE PATIENTS FAILURE TO TNF INHIBITORS

Catalog

Books, media, physical & digital resources